In this study, we identified an important LM‐associated oncogene, CRIP1, and confirmed that CRIP1 effectively promoted the development of LM in GC through enhancing lymphangiogenesis and lymphatic permeability. The gene discussed is CRIP1; the disease is gastric cancer.